The company will partner with its global biologics research and development arm MedImmune to carry out the genomics initiative, along with collaborators Human Longevity of the U.S, the Wellcome Trust Sanger Institute of the U.K. and The Institute for Molecular Medicine of Finland.
“Using the power of genomics is the foundation of our ambition to develop the most innovative and impactful treatments for patients,” said Menelas Pangalos, executive vice president of innovative medicines and early development at AstraZeneca. “With the advent of next generation sequencing and the increased sophistication of data analysis, the time is now right to immerse ourselves fully in the international genomics community through these pioneering collaborations and through the creation of our own genome center.”
More articles on genomics:
Intermountain, Stanford establish research program focused on precision health: 6 things to know
Physicians offer patients little insight on their genomic testing results
9 questions about precision medicine, answered
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
